These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37984442)

  • 1. Altered HCAR3 expression may underlying the blunted niacin responses of the psychiatric disorders and the risk of schizophrenia.
    Jiang J; Wang D; Gao Y; Sun L; Li S; Hu X; Li Z; Zhang J; Ji F; Tian Y; Guan L; Li Z; He L; Wan C
    Psychiatry Clin Neurosci; 2024 Feb; 78(2):123-130. PubMed ID: 37984442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases.
    McGuire Sams C; Shepp K; Pugh J; Bishop MR; Merner ND
    BMC Med Genomics; 2021 Dec; 14(1):284. PubMed ID: 34852802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association Study.
    Periyasamy S; John S; Padmavati R; Rajendren P; Thirunavukkarasu P; Gratten J; Vinkhuyzen A; McRae A; Holliday EG; Nyholt DR; Nancarrow D; Bakshi A; Hemani G; Nertney D; Smith H; Filippich C; Patel K; Fowdar J; McLean D; Tirupati S; Nagasundaram A; Gundugurti PR; Selvaraj K; Jegadeesan J; Jorde LB; Wray NR; Brown MA; Suetani R; Giacomotto J; Thara R; Mowry BJ
    JAMA Psychiatry; 2019 Oct; 76(10):1026-1034. PubMed ID: 31268507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
    Yang X; Wei W; Tan S; Guo L; Qiao S; Yao B; Wang Z
    World J Surg Oncol; 2021 Aug; 19(1):248. PubMed ID: 34419055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The high-affinity niacin receptor HM74A is decreased in the anterior cingulate cortex of individuals with schizophrenia.
    Miller CL; Dulay JR
    Brain Res Bull; 2008 Sep; 77(1):33-41. PubMed ID: 18639743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of HCAR2 by niacin: benefits beyond lipid lowering.
    Tuteja S
    Pharmacogenomics; 2019 Nov; 20(16):1143-1150. PubMed ID: 31617441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of phospholipase and cyclooxygenase expression is involved in Schizophrenia.
    Yang X; Li M; Jiang J; Hu X; Qing Y; Sun L; Yang T; Wang D; Cui G; Gao Y; Zhang J; Li X; Shen Y; Qin S; Wan C
    EBioMedicine; 2021 Feb; 64():103239. PubMed ID: 33581645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia.
    Lien YJ; Huang SS; Liu CM; Hwu HG; Faraone SV; Tsuang MT; Chen WJ
    Schizophr Bull; 2013 Jan; 39(1):68-76. PubMed ID: 21653277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The niacin response biomarker as a schizophrenia endophenotype: A status update.
    Messamore E
    Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():95-97. PubMed ID: 28688777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship of Common Risk Variants and Polygenic Risk for Schizophrenia to Sensorimotor Gating.
    Roussos P; Giakoumaki SG; Zouraraki C; Fullard JF; Karagiorga VE; Tsapakis EM; Petraki Z; Siever LJ; Lencz T; Malhotra A; Spanaki C; Bitsios P
    Biol Psychiatry; 2016 Jun; 79(12):988-96. PubMed ID: 26212897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association study of multiplex schizophrenia pedigrees.
    Levinson DF; Shi J; Wang K; Oh S; Riley B; Pulver AE; Wildenauer DB; Laurent C; Mowry BJ; Gejman PV; Owen MJ; Kendler KS; Nestadt G; Schwab SG; Mallet J; Nertney D; Sanders AR; Williams NM; Wormley B; Lasseter VK; Albus M; Godard-Bauché S; Alexander M; Duan J; O'Donovan MC; Walsh D; O'Neill A; Papadimitriou GN; Dikeos D; Maier W; Lerer B; Campion D; Cohen D; Jay M; Fanous A; Eichhammer P; Silverman JM; Norton N; Zhang N; Hakonarson H; Gao C; Citri A; Hansen M; Ripke S; ; Dudbridge F; Holmans PA
    Am J Psychiatry; 2012 Sep; 169(9):963-73. PubMed ID: 22885689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Variants Shared Between Smoking Quantity and Schizophrenia on 15q25 Are Associated With CHRNA5 Expression in the Brain.
    Ohi K; Kuwata A; Shimada T; Kataoka Y; Yasuyama T; Uehara T; Kawasaki Y
    Schizophr Bull; 2019 Jun; 45(4):813-823. PubMed ID: 30202994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
    Cross-Disorder Group of the Psychiatric Genomics Consortium
    Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia.
    Yao JK; Dougherty GG; Gautier CH; Haas GL; Condray R; Kasckow JW; Kisslinger BL; Gurklis JA; Messamore E
    Schizophr Bull; 2016 Mar; 42(2):369-76. PubMed ID: 26371338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker.
    Wang DD; Hu XW; Jiang J; Sun LY; Qing Y; Yang XH; Gao Y; Cui GP; Li MH; Wang PK; Zhang J; Zhuang Y; Li ZZ; Li J; Guan LL; Zhang TH; Wang JJ; Ji F; Wan CL
    Schizophr Res; 2021 Apr; 230():53-60. PubMed ID: 33677199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
    Jiang X; Deng Q; Stener-Victorin E
    Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the Niacin-Blunted Subgroup of Schizophrenia Patients from Mood Disorders and Healthy Individuals in Chinese Population.
    Sun L; Yang X; Jiang J; Hu X; Qing Y; Wang D; Yang T; Yang C; Zhang J; Yang P; Wang P; Cai C; Wang J; He L; Wan C
    Schizophr Bull; 2018 Jun; 44(4):896-907. PubMed ID: 29077970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future of GPR109A agonists in the treatment of dyslipidaemia.
    Wanders D; Judd RL
    Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Integration of Brain eQTL and GWAS Identifies ZNF323 as a Novel Schizophrenia Risk Gene and Suggests Recent Positive Selection Based on Compensatory Advantage on Pulmonary Function.
    Luo XJ; Mattheisen M; Li M; Huang L; Rietschel M; Børglum AD; Als TD; van den Oord EJ; Aberg KA; Mors O; Mortensen PB; Luo Z; Degenhardt F; Cichon S; Schulze TG; Nöthen MM; ; ; Su B; Zhao Z; Gan L; Yao YG
    Schizophr Bull; 2015 Nov; 41(6):1294-308. PubMed ID: 25759474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
    Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
    Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.